Ads
related to: ionis nasdaq- Streamlined Solutions
Explore Fidelity's Business Options
to Help You Meet Your Goals
- Contact Us
For Clearing and Custody Resources
& Support for Long-Term Growth
- RIAs
Fidelity's Collaborative Approach
Can Help You Grow Your RIA Business
- Client-Focused Service
Fidelity Can Help Businesses
Better Support Clients
- Streamlined Solutions
invesco.com has been visited by 100K+ users in the past month
Search results
Shareholders Will Probably Not Have Any Issues With Ionis Pharmaceuticals, Inc.'s (NASDAQ:IONS) CEO...
Simply Wall St. via Yahoo Finance· 1 day agoKey Insights Ionis Pharmaceuticals' Annual General Meeting to take place on 6th of June Salary of...
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 weeks agoIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Q1 2024 Earnings Call Transcript May 7, 2024 Ionis...
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Just Released Its Yearly Results And Analysts Are Updating...
Simply Wall St. via Yahoo Finance· 3 months agoIonis Pharmaceuticals, Inc. (NASDAQ:IONS) defied analyst predictions to release its annual results,...
The Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) First-Quarter Results Are Out And Analysts Have...
Simply Wall St. via Yahoo Finance· 3 weeks agoIonis Pharmaceuticals, Inc. (NASDAQ:IONS) shareholders are probably feeling a little disappointed,...
Institutional investors in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) lost 4.6% last week but have...
Simply Wall St. via Yahoo Finance· 1 year agoEvery investor in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) should be aware of the most powerful...
Ionis Pharmaceuticals (NASDAQ:IONS) shareholders have earned a 23% return over the last year
Simply Wall St. via Yahoo Finance· 6 months agoThese days it's easy to simply buy an index fund, and your returns should (roughly) match the...
Ionis Pharmaceuticals Inc (IONS) Reports Q3 2023 Financial Results
GuruFocus.com via Yahoo Finance· 7 months agoIonis Pharmaceuticals Inc (NASDAQ:IONS) reported Q3 2023 financial results on November 2, 2023....
Is Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Trading At A 29% Discount?
Simply Wall St. via Yahoo Finance· 7 months agoKey Insights Ionis Pharmaceuticals' estimated fair value is US$66.44 based on 2 Stage Free Cash Flow...
Ionis Pharmaceuticals (NASDAQ:IONS) shareholders have endured a 41% loss from investing in the stock...
Simply Wall St. via Yahoo Finance· 1 year agoIn order to justify the effort of selecting individual stocks, it's worth striving to beat the...
Ionis Pharmaceuticals Inc (IONS) Surpasses Revenue Guidance for 2023, Sets Sights on 2024 Growth
GuruFocus.com via Yahoo Finance· 3 months agoTotal Revenue: Increased to $788 million in 2023 from $587 million in 2022. Operating Expenses: Rose...